As
Congress finalizes plans to expand Medicare, more and more seniors
are beginning to understand that free prescription
drugs from the government will carry a very high price tag. The
tragedy is that our society is allowing the pharmaceutical industry,
phony senior lobbies, and vote-hungry politicians to force millions
of older Americans into a government-run Medicare ghetto.
All of us,
including seniors, will pay for the drug benefit in the form of
higher taxes. Congress claims the program will cost $400 billion
over the next 10 years, but government cost projections cannot
be trusted. Medicare today costs seven times more than originally
estimated. Private economists estimate the true cost will be closer
to $3 or $4 trillion over ten years, but even the governments
figure of $400 billion represents the largest entitlement increase
since the failed Great Society programs of the 1960s. This new
spending comes as the Treasury faces record single-year deficits,
which soon will approach $1 trillion annually.
The biggest
losers under the new program are the 76% of seniors who already
have some form of prescription drug coverage. On average, these
seniors spend less than $1,000 per year on drug co-payments and
meeting deductible amounts. Under both the House and Senate proposals,
however, millions of American seniors will end up paying more
out-of-pocket for drugs than they do now, while having worse coverage.
Furthermore,
the Medicare drug benefit gives private companies a perverse incentive
to dump their existing prescription coverage and force retirees
into the government system. Many large companies already have
badly underfunded pension plans. As more and more Baby Boomers
retire, these companies will face serious financial crises. They
will naturally seek to cut costs by eliminating drug coverage;
some companies already have announced their intention to do so
when the Medicare drug benefit becomes available. In fact, the
Congressional Budget Office estimates that at least one-third
of all retirees will lose their private drug coverage and becomes
wards of Medicare.
Prescription
drugs are tremendously expensive, but the solution is not a wasteful
new one-size-fits-all government drug entitlement. To lower drug
prices, we must eliminate government interference that prevents
healthy free-market price competition.
First and
foremost, we must eliminate the middleman in health care. The
HMO Act of 1973, coupled with tax rules that do not allow individuals
to use pre-tax dollars to pay for health care, combine to force
millions of Americans to deal with HMO and Medicare bureaucrats.
Whenever a third-party stands between a doctor and his patient,
health care becomes inefficient and expensive. Individuals should
be able to decide with their doctors what drugs are appropriate,
and then reduce their taxable income dollar-for-dollar for all
drug expenditures. By forcing employers to offer HMOs and prohibiting
individuals from paying for drugs with pre-tax dollars, government
enables drug companies to set high prices for deep-pocket middlemen.
The Food
and Drug Administration is also directly responsible for high
drug costs. Pharmaceutical companies spend hundreds of millions
of dollars to bring a single drug to market because of FDA rules.
Often FDA approval is never obtained, no matter how much a company
spends developing a drug. So pharmaceutical makers naturally try
to recoup their huge investments by charging high prices and lobbying
to keep exclusive drug patent periods as lengthy as possible.
We need to understand that the FDA does far more harm than good,
both in terms of drug prices and the incalculable chilling effect
it has on needed drug research. With less FDA interference, patents
could be shortened and drug development costs reduced. This would
allow greater price competition between drug companies.
The
new Medicare drug plan enriches pharmaceutical companies, fleeces
taxpayers, and forces millions of older Americans to accept inferior
drug coverage. It does nothing, however, to address the fundamental
reasons prescription drugs cost so much.
October
7, 2003